- 23 Dec 2021
- ICICI Securities
Additional purchase of Molnupiravir from UK
DIVISLAB - 3630 Change: 47.05 (1.31 %)News: The UK government has agreed with Merck to purchase additional 1.75 million courses of molnupiravir (total 2.23 million courses).
Views: In the backdrop of USFDA authorising Pfizer's Paxlovid for oral antiviral treatment of Covid-19, further order book for Molnupiravir from UK along with supply agreement for 3.1 million courses to US and supply agreements with over 30 countries, has kept the Molnupiravir opportunity intact.
Impact: Positive.